INVESTOR ALERT: Centessa Pharmaceuticals plc Investors with Substantial Losses Have Opportunity to…
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Centessa Pharmaceuticals plc (NASDAQ: CNTA): (i) American Depositary Shares (“ADSs”) pursuant and/or traceable to the…